XW Laboratories
Wuhan
About XW Laboratories
XW Laboratories is an Asia-Pacific biopharmaceutical company dedicated to discovering and developing transformational medicines that will markedly improve the quality of life in patients suffering from neurological disorders. Founded in 2014, XW Laboratories has developed 3 unique drug R&D platforms that not only allow us to improve upon existing medication through approaches such as prodrug and functional group switch, but also be at the forefront of medicinal technology in immunoneurology through the application of their mitochondria-targeting platform.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $57.5M
- Funding stage: Late Stage Venture
- Last round: Series C (Sep 2020)
- Website: xwpharma.com
- Phone: +862787635677
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/xw-laboratories-16365 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.